Usefulness of Pre-biopsy Multiparametric Magnetic Resonance Imaging and Clinical Variables to Reduce Initial Prostate Biopsy in Men with Suspected Clinically Localized Prostate Cancer

Kawakami, 2008, Development, validation, and head-to-head comparison of logistic regression-based nomograms and artificial neural network models predicting prostate cancer on initial extended biopsy, Eur Urol, 54, 601, 10.1016/j.eururo.2008.01.017 Draisma, 2009, Lead time and over diagnosis in prostate-specific antigen screening: importance of methods and context, J Natl Cancer Inst, 101, 374, 10.1093/jnci/djp001 Wilt, 2012, Radical prostatectomy versus observation for localized prostate cancer, N Engl J Med, 367, 203, 10.1056/NEJMoa1113162 Pinkhasov, 2012, Complications following prostate needle biopsy requiring hospital admission or emergency department visits—experience from 1000 consecutive cases, BJU Int, 110, 369, 10.1111/j.1464-410X.2011.10926.x Loeb, 2011, Complications after prostate biopsy: data from SEER-Medicare, J Urol, 186, 1830, 10.1016/j.juro.2011.06.057 Barentsz, 2012, ESUR prostate MR guidelines 2012, Eur Radiol, 22, 746, 10.1007/s00330-011-2377-y Dickinson, 2011, Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting, Eur Urol, 59, 477, 10.1016/j.eururo.2010.12.009 Hoeks, 2011, Prostate cancer: multiparametric MR imaging for detection, localization, and staging, Radiology, 261, 46, 10.1148/radiol.11091822 Ahmed, 2009, Is it time to consider a role for MRI before prostate biopsy?, Nat Rev Clin Oncol, 6, 197, 10.1038/nrclinonc.2009.18 Hoang, 2012, Image guidance in the focal treatment of prostate cancer, Curr Opin Urol, 22, 328, 10.1097/MOU.0b013e32835482cc Margel, 2012, Impact of multiparametric endorectal coil prostate magnetic resonance imaging on disease reclassification among active surveillance candidates: a prospective cohort study, J Urol, 187, 1247, 10.1016/j.juro.2011.11.112 Kumar, 2008, Potential of magnetic resonance spectroscopic imaging in predicting absence of prostate cancer in men with serum prostate-specific antigen between 4 and 10 ng/ml: a follow-up study, Urology, 72, 859, 10.1016/j.urology.2008.01.014 Vilanova, 2011, Usefulness of pre-biopsy multifunctional and morphologic MRI combined with free-to-total prostate-specific antigen ratio in the detection of prostate cancer, AJR Am J Roentgenol, 196, W715, 10.2214/AJR.10.5700 Numao, 2007, Improved accuracy in predicting the presence of Gleason pattern 4/5 prostate cancer by three-dimensional 26-core systematic biopsy, Eur Urol, 52, 1663, 10.1016/j.eururo.2007.01.025 Epstein, 2005, The 2005 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma, Am J Surg Pathol, 29, 1228, 10.1097/01.pas.0000173646.99337.b1 Dall'Era, 2012, Active surveillance for prostate cancer: a systematic review of the literature, Eur Urol, 62, 976, 10.1016/j.eururo.2012.05.072 Lawrentschuk, 2011, Active surveillance for low-risk prostate cancer: an update, Nat Rev Urol, 8, 312, 10.1038/nrurol.2011.50 Cooperberg, 2011, Active surveillance for prostate cancer: progress and promise, J Clin Oncol, 29, 3669, 10.1200/JCO.2011.34.9738 Nam, 2007, Assessing individual risk for prostate cancer, J Clin Oncol, 25, 3582, 10.1200/JCO.2007.10.6450 Pinto, 2011, Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging, J Urol, 186, 1281, 10.1016/j.juro.2011.05.078 Hambrock, 2012, Prospective assessment of prostate cancer aggressiveness using 3-T diffusion-weighted magnetic resonance imaging-guided biopsies versus a systematic 10-core transrectal ultrasound prostate biopsy cohort, Eur Urol, 61, 177, 10.1016/j.eururo.2011.08.042 Moore, 2013, Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic review, Eur Urol, 63, 125, 10.1016/j.eururo.2012.06.004 Ahmed, 2011, Characterizing clinically significant prostate cancer using template prostate mapping biopsy, J Urol, 186, 458, 10.1016/j.juro.2011.03.147 Rouse, 2011, Multi-parametric magnetic resonance imaging to rule-in and rule-out clinically important prostate cancer in men at risk: a cohort study, Urol Int, 87, 49, 10.1159/000325880 van den Bergh, 2009, Outcomes of men with screen-detected prostate cancer eligible for active surveillance who were managed expectantly, Eur Urol, 55, 1, 10.1016/j.eururo.2008.09.007 Billis, 2008, The impact of the 2005 International Society of Urological Pathology consensus conference on standard Gleason grading of prostatic carcinoma in needle biopsies, J Urol, 180, 548, 10.1016/j.juro.2008.04.018 Dong, 2012, Impact on the clinical outcome of prostate cancer by the 2005 international society of urological pathology modified Gleason grading system, Am J Surg Pathol, 36, 838, 10.1097/PAS.0b013e3182486faf Ploussard, 2011, The contemporary concept of significant versus insignificant prostate cancer, Eur Urol, 60, 291, 10.1016/j.eururo.2011.05.006 Kitajima, 2010, Prostate cancer detection with 3 T MRI: comparison of diffusion-weighted imaging and dynamic contrast-enhanced MRI in combination with T2-weighted imaging, J Magn Reson Imaging, 31, 625, 10.1002/jmri.22075